TY - JOUR
T1 - Autosomal recessive hereditary spastic paraplegia
T2 - A rare case of a family with phenotypic variation
AU - Saban, Mor
AU - Shachar, Tal
N1 - Publisher Copyright:
© 2020 Bentham Science Publishers.
PY - 2020
Y1 - 2020
N2 - Background: Hereditary spastic paraplegia is a neurodegenerative disorder with a pure and complex form. More than 50 genetic types are currently known, with different ages of onset for characteristic symptoms. Data regarding hereditary spastic paraplegia remain scarce, and the rare subtype of spastic paraplegia type 5 is no exception. Objective: This report presents data regarding the case of a single family, from the city of Djerba, with five individuals affected with hereditary spastic paraplegia, the largest number of spastic paraplegia type 5 mutated family members so far reported in current litera-ture. Methods: To emphasize the importance of genetic testing, we retrospectively reviewed a familial confirmed case of hereditary spastic paraplegia. Clinical features of family members were described. Results: The family presents a large phenotypic variation that, in part, differs from the known phenotypic presentations. Age of onset and clinical manifestation showed interfa-milial variations. The alteration found in CYP7B1 (c.1081C>T; p.R361*) may help emphasize the importance of genetic testing and the much-needed treatment options already in use in current neurological practice. Conclusion: The understanding of the molecular pathways of hereditary spastic paraple-gia, together with the establishment of disease biomarkers, will hopefully lead to better and more personalized treatment.
AB - Background: Hereditary spastic paraplegia is a neurodegenerative disorder with a pure and complex form. More than 50 genetic types are currently known, with different ages of onset for characteristic symptoms. Data regarding hereditary spastic paraplegia remain scarce, and the rare subtype of spastic paraplegia type 5 is no exception. Objective: This report presents data regarding the case of a single family, from the city of Djerba, with five individuals affected with hereditary spastic paraplegia, the largest number of spastic paraplegia type 5 mutated family members so far reported in current litera-ture. Methods: To emphasize the importance of genetic testing, we retrospectively reviewed a familial confirmed case of hereditary spastic paraplegia. Clinical features of family members were described. Results: The family presents a large phenotypic variation that, in part, differs from the known phenotypic presentations. Age of onset and clinical manifestation showed interfa-milial variations. The alteration found in CYP7B1 (c.1081C>T; p.R361*) may help emphasize the importance of genetic testing and the much-needed treatment options already in use in current neurological practice. Conclusion: The understanding of the molecular pathways of hereditary spastic paraple-gia, together with the establishment of disease biomarkers, will hopefully lead to better and more personalized treatment.
KW - CYP7B1
KW - Djerba
KW - Hereditary spastic paraplegia
KW - Mutation
KW - Phenotype
KW - SPG5
UR - http://www.scopus.com/inward/record.url?scp=85100899845&partnerID=8YFLogxK
U2 - 10.2174/1875692117999201211142908
DO - 10.2174/1875692117999201211142908
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:85100899845
SN - 1875-6921
VL - 17
SP - 211
EP - 215
JO - Current Pharmacogenomics and Personalized Medicine
JF - Current Pharmacogenomics and Personalized Medicine
IS - 3
ER -